-
Effect of exenatide twice daily and dapagliflozin, alone and in combination, on markers of kidney function in obese patients with type 2 diabetes: A prespecified secondary analysis of a randomized controlled clinical trial
van Ruiten, C. C., van der Aart-van der Beek, A. B., IJzerman, R. G., Nieuwdorp, M., Hoogenberg, K., van Raalte, D. H. & Heerspink, H. J. L., Aug 2021, In: Diabetes, obesity & metabolism. 23, 8, p. 1851-1858 8 p.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
